Garnerville, NY, United States of America

Wu Ruoqiu


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wu Ruoqiu: Innovator in HCV Treatment

Introduction

Wu Ruoqiu is a notable inventor based in Garnerville, NY (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the treatment of Hepatitis C Virus (HCV). His innovative work has led to the development of new compounds that hold promise for effective antiviral therapies.

Latest Patents

Wu Ruoqiu holds a patent for 4-ethynyl pyrazole derivative compounds and methods for the treatment of HCV. This patent includes aryl substituted pyrazole derivatives and outlines processes for their preparation. The invention also provides compositions and methods for treating HCV by administering these compounds, either alone or in combination with additional antiviral agents, in a therapeutically effective amount.

Career Highlights

Wu Ruoqiu is associated with XTL Biopharmaceuticals Ltd., where he continues to advance research in antiviral treatments. His work is characterized by a commitment to developing innovative solutions for complex health challenges.

Collaborations

He collaborates with esteemed colleagues such as Guolin Li and Reza Fathi, contributing to a dynamic research environment focused on biopharmaceutical advancements.

Conclusion

Wu Ruoqiu's contributions to the field of HCV treatment through his innovative patents and collaborations highlight his role as a key figure in biopharmaceutical research. His work continues to pave the way for new therapeutic options in the fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…